ZP General Partner 3 ApS: Financial statements 2020
CVR: 41023422
Source: annual report 2020, Danish Business Authority
09/12/2019 – 31/12/2020
ZP General Partner 3 ApS (CVR 41023422) has filed annual accounts for 2020. In 2020, the company reported revenue of USD 280,000 and a net result of USD 218,000. The profit margin was 77.9%. Equity in the 2020 report amounted to USD 245,000. The solvency ratio was 78.3%.
- Revenue
- USD 280,000
- Gross Profit
- USD -279,000
- Profit/Loss
- USD 218,000
- Equity
- USD 245,000
- Total Assets
- USD 313,000
Official annual report
How creditworthy is ZP General Partner 3 ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout ZP General Partner 3 ApS
ZP General Partner 3 ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The company is owned by ZEALAND PHARMA A/S. In 2025, the company reported revenue of DKK 1,000 and a net result of DKK -29,000 compared with DKK -18,000 the year before. Equity in the 2025 report amounted to DKK 30,000.